Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sex differences in Alzheimer disease — the gateway to precision medicine
Maria Teresa Ferretti, M. Florencia Iulita, Enrica Cavedo, et al.
Nature Reviews Neurology (2018) Vol. 14, Iss. 8, pp. 457-469
Closed Access | Times Cited: 725

Showing 1-25 of 725 citing articles:

Sex and gender: modifiers of health, disease, and medicine
Franck Mauvais‐Jarvis, C. Noel Bairey Merz, Peter J. Barnes, et al.
The Lancet (2020) Vol. 396, Iss. 10250, pp. 565-582
Open Access | Times Cited: 1451
The Sleep-Immune Crosstalk in Health and Disease
Luciana Besedovsky, Tanja Lange, Monika Haack
Physiological Reviews (2019) Vol. 99, Iss. 3, pp. 1325-1380
Open Access | Times Cited: 1050
The Major Risk Factors for Alzheimer’s Disease: Age, Sex, and Genes Modulate the Microglia Response to Aβ Plaques
Carlo Sala Frigerio, Leen Wolfs, Nicola Fattorelli, et al.
Cell Reports (2019) Vol. 27, Iss. 4, pp. 1293-1306.e6
Open Access | Times Cited: 680
Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic
Harald Hampel, Sid E. O’Bryant, José Luís Molinuevo, et al.
Nature Reviews Neurology (2018) Vol. 14, Iss. 11, pp. 639-652
Open Access | Times Cited: 552
Current state of Alzheimer’s fluid biomarkers
José Luís Molinuevo, Scott Ayton, Richard Batrla, et al.
Acta Neuropathologica (2018) Vol. 136, Iss. 6, pp. 821-853
Open Access | Times Cited: 444
Global estimates on the number of persons across the Alzheimer's disease continuum
Anders Gustavsson, Nicholas Norton, Thomas N. Fast, et al.
Alzheimer s & Dementia (2022) Vol. 19, Iss. 2, pp. 658-670
Open Access | Times Cited: 435
Sex and gender differences and biases in artificial intelligence for biomedicine and healthcare
Davide Cirillo, Silvina Catuara‐Solarz, Czuee Morey, et al.
npj Digital Medicine (2020) Vol. 3, Iss. 1
Open Access | Times Cited: 382
Decreased Serum Brain-Derived Neurotrophic Factor (BDNF) Levels in Patients with Alzheimer’s Disease (AD): A Systematic Review and Meta-Analysis
Ted Kheng Siang Ng, Cyrus S. H. Ho, Wilson Tam, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 2, pp. 257-257
Open Access | Times Cited: 332
Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer’s continuum when only subtle changes in Aβ pathology are detected
Marc Suárez‐Calvet, Thomas K. Karikari, Nicholas J. Ashton, et al.
EMBO Molecular Medicine (2020) Vol. 12, Iss. 12
Open Access | Times Cited: 292
Microglia in Alzheimer Disease: Well-Known Targets and New Opportunities
Anne-Laure Hemonnot-Girard, Jennifer Hua, Lauriane Ulmann, et al.
Frontiers in Aging Neuroscience (2019) Vol. 11
Open Access | Times Cited: 289
Stress, sex hormones, inflammation, and major depressive disorder: Extending Social Signal Transduction Theory of Depression to account for sex differences in mood disorders
George M. Slavich, Julia Sacher
Psychopharmacology (2019) Vol. 236, Iss. 10, pp. 3063-3079
Open Access | Times Cited: 285
Dump the “dimorphism”: Comprehensive synthesis of human brain studies reveals few male-female differences beyond size
Lise Eliot, Adnan Ahmed, Hiba Khan, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 125, pp. 667-697
Open Access | Times Cited: 274
Dopamine and Dopamine Receptors in Alzheimer's Disease: A Systematic Review and Network Meta-Analysis
Xiongfeng Pan, Atipatsa Chiwanda Kaminga, Shi Wu Wen, et al.
Frontiers in Aging Neuroscience (2019) Vol. 11
Open Access | Times Cited: 200
Toward personalized cognitive diagnostics of at-genetic-risk Alzheimer’s disease
Gillian Coughlan, Antoine Coutrot, Mizanur Khondoker, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 19, pp. 9285-9292
Open Access | Times Cited: 169
Increased Alzheimer's risk during the menopause transition: A 3-year longitudinal brain imaging study
Lisa Mosconi, Aneela Rahman, Iván Díaz, et al.
PLoS ONE (2018) Vol. 13, Iss. 12, pp. e0207885-e0207885
Open Access | Times Cited: 166
Pathways Connecting Late-Life Depression and Dementia
Christoph Linnemann, Undine E. Lang
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 165
The neuroimmune axis of Alzheimer’s disease
Mehdi Jorfi, Anna Maaser-Hecker, Rudolph E. Tanzi
Genome Medicine (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 165
Sex differences in movement disorders
Sara Meoni, Antonella Macerollo, Elena Moro
Nature Reviews Neurology (2020) Vol. 16, Iss. 2, pp. 84-96
Closed Access | Times Cited: 162
Persistent metabolic youth in the aging female brain
Manu S. Goyal, Tyler Blazey, Yi Su, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 8, pp. 3251-3255
Open Access | Times Cited: 161
Menopause impacts human brain structure, connectivity, energy metabolism, and amyloid-beta deposition
Lisa Mosconi, Valentina Berti, Jonathan P. Dyke, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 155
Alzheimer’s pathogenic mechanisms and underlying sex difference
Donghui Zhu, Axel Montagne, Zhen Zhao
Cellular and Molecular Life Sciences (2021) Vol. 78, Iss. 11, pp. 4907-4920
Open Access | Times Cited: 155
Sex and APOE ε4 genotype modify the Alzheimer’s disease serum metabolome
Matthias Arnold, Kwangsik Nho, Alexandra Kueider‐Paisley, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 154
Sex Differences in Alzheimer’s Disease: Insights From the Multiomics Landscape
Lei Guo, Margaret B. Zhong, Larry Zhang, et al.
Biological Psychiatry (2021) Vol. 91, Iss. 1, pp. 61-71
Open Access | Times Cited: 126
Alzheimer’s disease: Insights and new prospects in disease pathophysiology, biomarkers and disease-modifying drugs
Ana Rita Monteiro, Daniel José Barbosa, Fernando Remião, et al.
Biochemical Pharmacology (2023) Vol. 211, pp. 115522-115522
Open Access | Times Cited: 112
Designing the next-generation clinical care pathway for Alzheimer’s disease
Harald Hampel, Rhoda Au, Soeren Mattke, et al.
Nature Aging (2022) Vol. 2, Iss. 8, pp. 692-703
Open Access | Times Cited: 107
Page 1 - Next Page

Scroll to top